2018 International Congress Archives - Page 28 of 177

1:45pm-3:15pm: Final MDS-UPDRS, Part IV Results of the EASE LID 2 Study: Long Term, Open-Label Study of ADS-5102 for Dyskinesia in Parkinson’s disease (PD) patients

R. Hauser, R. Pahwa, C. Tanner, W. Oertel, R. Johnson, L. Felt, MJ. Stempien, R. Patni (Tampa, FL, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Final Safety Results of EASE LID 2 Study: Long Term Open-Label Study of ADS-5102 for Dyskinesia in Parkinson’s disease (PD) patients

S. Isaacson, R. Pahwa, C. Tanner, R. Hauser, W. Oertel, R. Johnson, L. Felt, M.J. Stempien, R. Patni (Boca Raton, FL, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: First Results from the Ixcellence Network® Survey: Botulinum Neurotoxin-A Usage and Training in Cervical Dystonia & Spastic Paresis

R. Bhidayasiri, K. Bahtia, L.J. Jacinto, TM. Chung, T. Landreau, C. Colosimo (Bangkok, Thailand)

Education in Movement Disorders · Hall 3FG

1:45pm-3:15pm: Five Year Outcomes of a Prospective, Multicenter Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s Disease

L. Timmermann, R. Jain, N. Van Dyck, L. Chen, T. Brücke, F. Siejo, E. Suarez-San Martin, V. Visser-Vandewalle, M. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Köln, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Frequency-dependent effects of subthalamic deep brain stimulation on motor symptoms in Parkinson’s disease

D. Su, W. Hu, H. Chen, J. Zhou, T. Feng (Beijing, China)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: From Non-rechargeable to Rechargeable Technology: Insights and Management of Pallidal Deep Brain Stimulation in Dystonia after Switching to a Rechargeable Implantable Pulse Generator

M. Wolf, A. Saryyeva, D. Schulte, J. Krauss, C. Blahak (Mannheim, Germany)

Surgical Therapy: Other Movement Disorders · Hall 3FG

1:45pm-3:15pm: Functional Conundrum in Wilson’s Disease

S. Raju (Bengaluru, India)

Myoclonus · Hall 3FG

1:45pm-3:15pm: Future doctors as health educators: Undergraduate medical students raise awareness and unite for Parkinson’s disease

S. El-Jaafary, H. Amer, A. Fouad, B. Tawfiq, L. El Sabbahy, A. Bayoumy, B. Abulkarim, B. Gamal, H. Nafea, H. Shehata, M. El-Tamawy (Cairo, Egypt)

Education in Movement Disorders · Hall 3FG

1:45pm-3:15pm: Gait disorders in Parkinson’s disease: 19 observations at the University Hospital Center of Conakry

F. Sakadi, C. Abass, T. Rahamatou, B. Talibé, N. Woga, B. Kenda, C. Amara (Conakry, Guinea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Gait speed after applying anodal-transcranial Direct Current Stimulation in people with Parkinson’s disease? Preliminary results

V. Alizad, M. Meinzer, L. Frossard, R. Polman, S. Smith, G. Kerr (Brisbane, Australia)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG